254 related articles for article (PubMed ID: 9458237)
21. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
22. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
Kramm CM; Rainov NG; Sena-Esteves M; Barnett FH; Chase M; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Oct; 7(16):1989-94. PubMed ID: 8930659
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
[TBL] [Abstract][Full Text] [Related]
25. Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells.
Vrionis FD; Wu JK; Qi P; Cano WG; Cherington V
J Neurooncol; 1996 Dec; 30(3):225-36. PubMed ID: 8943097
[TBL] [Abstract][Full Text] [Related]
26. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy.
Estin D; Li M; Spray D; Wu JK
Neurosurgery; 1999 Feb; 44(2):361-8; discussion 368-9. PubMed ID: 9932890
[TBL] [Abstract][Full Text] [Related]
27. Thymidine kinase-mediated killing of rat brain tumors.
Barba D; Hardin J; Ray J; Gage FH
J Neurosurg; 1993 Nov; 79(5):729-35. PubMed ID: 8410252
[TBL] [Abstract][Full Text] [Related]
28. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
29. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.
Touraine RL; Vahanian N; Ramsey WJ; Blaese RM
Hum Gene Ther; 1998 Nov; 9(16):2385-91. PubMed ID: 9829537
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.
Robe PA; Nguyen-Khac M; Jolois O; Rogister B; Merville MP; Bours V
BMC Cancer; 2005 Apr; 5():32. PubMed ID: 15804364
[TBL] [Abstract][Full Text] [Related]
32. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain.
Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.
Parsa AT; Chi JH; Hurley PT; Jeyapalan SA; Bruce JN
Neurosurgery; 2001 Sep; 49(3):681-8; discussion 688-9. PubMed ID: 11523680
[TBL] [Abstract][Full Text] [Related]
35. Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line.
Drake RR; Pitlyk K; McMasters RA; Mercer KE; Young H; Moyer MP
Mol Ther; 2000 Nov; 2(5):515-23. PubMed ID: 11082325
[TBL] [Abstract][Full Text] [Related]
36. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
38. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
[TBL] [Abstract][Full Text] [Related]
39. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
40. The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.
Colombo BM; Benedetti S; Ottolenghi S; Mora M; Pollo B; Poli G; Finocchiaro G
Hum Gene Ther; 1995 Jun; 6(6):763-72. PubMed ID: 7548276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
